Peptide PartnersRetatrutide
GLP-3 Retatrutide (12mg vials)
12 mg· 12 mg vial· 99.65% purity· vial
Triple hormone receptor agonist targeting GIP, GLP-1, and glucagon receptors for research use.
Tap I use this — we'll set up your dose, reminders & journey in 30 seconds.
Vendor price
USD 137.00
unknown
About this product
This product is solely intended for research purposes as a chemical compound. Its designation permits its use exclusively for in vitro testing and laboratory experimentation. All information regarding this product provided on our website is purely educational. By law, any form of bodily introduction of this product into humans or animals is strictly prohibited. It should only be handled by professionals who are licensed and qualified. This product is neither a drug, food, nor cosmetic, and must not be misrepresented, misused, or mislabeled as such.
Specifications
- Peptide
- Retatrutide
- Strength
- 12 mg
- Package
- 12 mg vial
- Purity
- 99.65%
- Form
- vial
More from Peptide Partners
Other products in catalog
Research-use only. Not for human or veterinary use. MyDosage does not sell or ship this product — purchases happen directly with Peptide Partners.